Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
| Preferred Name | Maraviroc | |
| Synonyms |
Celsentri MARAVIROC Maraviroc Selzentry UK 427,857 |
|
| Definitions |
A C-C Chemokine Receptor Type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C73144 |
|
| CAS_Registry |
376348-65-1
|
|
| CHEBI_ID |
CHEBI:63608
|
|
| Chemical_Formula |
C29H41F2N5O
|
|
| code |
C73144
|
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
| Contributing_Source |
CTRP FDA
|
|
| DEFINITION |
A C-C Chemokine Receptor Type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction.
|
|
| Display_Name |
Maraviroc
|
|
| FDA_UNII_Code |
MD6P741W8A
|
|
| FULL_SYN |
Celsentri MARAVIROC Maraviroc Selzentry UK 427,857
|
|
| Has_Target | ||
| label |
Maraviroc
|
|
| Legacy Concept Name |
Maraviroc
|
|
| NCI_Drug_Dictionary_ID |
696304
|
|
| PDQ_Closed_Trial_Search_ID |
696304
|
|
| PDQ_Open_Trial_Search_ID |
696304
|
|
| Preferred_Name |
Maraviroc
|
|
| prefixIRI |
Thesaurus:C73144
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C1667052
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping